Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (71-80 of 487) with videos related to

Pageof 49
Sort By:
Haematologica|June 16, 2022
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatmentJames B Bussel, Christine A Garcia
Cancer Treatment and Research|November 6, 2010
EltrombopagJames B Bussel, Mariana P Pinheiro
Seminars in Hematology|August 15, 2000
Idiopathic immune thrombocytopenic purpura: an updateJ G Kelton, J B Bussel
The Journal of Allergy and Clinical Immunology|February 20, 2003
21. Immunohematologic disordersDeepa H Trivedi, James B Bussel
Cancer Investigation|January 1, 1985
Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indicationsJ B Bussel, C Cunningham-Rundles
American Journal of Hematology|June 1, 1988
Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulinJ B Bussel, J S Haimi
Annals of Physical and Rehabilitation Medicine|July 21, 2015
Mechanisms underlying transcranial direct current stimulation in rehabilitationN Roche, M Geiger, B Bussel
Journal of Pediatric Hematology/Oncology|August 7, 2003
Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysisLinda J Butros, James B Bussel
Nature Clinical Practice. Gastroenterology & Hepatology|July 9, 2008
How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?James B Bussel, Kristen M Marks
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Romiplostim: a second-generation thrombopoietin agonistClaudia S Cohn, James B Bussel
Pageof 49

Showing results (71-80 of 487) with videos related to

Sort By:
Pageof 49
Haematologica|June 16, 2022
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatmentJames B Bussel, Christine A Garcia
Cancer Treatment and Research|November 6, 2010
EltrombopagJames B Bussel, Mariana P Pinheiro
Seminars in Hematology|August 15, 2000
Idiopathic immune thrombocytopenic purpura: an updateJ G Kelton, J B Bussel
The Journal of Allergy and Clinical Immunology|February 20, 2003
21. Immunohematologic disordersDeepa H Trivedi, James B Bussel
Cancer Investigation|January 1, 1985
Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indicationsJ B Bussel, C Cunningham-Rundles
American Journal of Hematology|June 1, 1988
Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulinJ B Bussel, J S Haimi
Annals of Physical and Rehabilitation Medicine|July 21, 2015
Mechanisms underlying transcranial direct current stimulation in rehabilitationN Roche, M Geiger, B Bussel
Journal of Pediatric Hematology/Oncology|August 7, 2003
Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysisLinda J Butros, James B Bussel
Nature Clinical Practice. Gastroenterology & Hepatology|July 9, 2008
How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?James B Bussel, Kristen M Marks
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Romiplostim: a second-generation thrombopoietin agonistClaudia S Cohn, James B Bussel
Pageof 49